Nephro Care India Limited
₹86.00▲ +0.60 (+0.70%)
NEPHROCARE·NSE·Healthcare
Market Cap
141.78 Cr
PE Ratio
42.16
Volume
4,400
Day High - Low
86.95 - 83.10
52W High-Low
156.35 - 50.05
₹86.00▲ +0.60 (+0.70%)
Market Cap141.78 Cr
PE Ratio42.16
Volume4,400
Day High - Low86.95 - 83.10
52W High-Low156.35 - 50.05
Nephro Care India Limited (NEPHROCARE): company summary
The company's revenue grew 92.8% annually, but net profit fell 7.4% year-on-year.
Nephro Care India Limited (NEPHROCARE) is a micro-cap Healthcare company valued at ₹142 crore operating in Hospital on the NSE and BSE.
- Recent price move
- Nephro Care India Limited last traded at ₹86, modestly up 0.70% on the day.
- Recent developments
- On 2026-06-30, the company reported a net profit of ₹2 crore for the latest quarter, reversing a net loss of ₹1 crore in the same quarter a year earlier. The promoter holding remained at 61.71% as of 2026-06-30, while foreign institutional holding increased by 0.23 percentage points to 0.96%.
- Financial performance
- The company's revenue grew 92.8% annually, but net profit fell 7.4% year-on-year. In the latest quarter, revenue rose 68.4% compared to the same quarter a year earlier, while net profit swung from a loss of ₹1 crore to a profit of ₹2 crore.
- Valuation multiples
- The stock trades at 42.2 times earnings, a premium to the Healthcare median of 32.0, 2.63 times book value.
- Things to watch
- The net profit margin narrowed 4.1 percentage points to 3.8%, and the company is not paying out dividends despite reporting repeated profits. The stock is 42.7% below its 52-week high.
- Where it stands
- The company has shown strong revenue growth, with a 92.8% annual increase and 68.4% rise in the latest quarter compared to the same quarter a year earlier. However, net profit margin has declined, and the stock is significantly below its 52-week high.
Summarised by DocStoX's model on 2026-10-04 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
DocStoX Score
4.3/10
Weak
Fair Value
Sign in to see
ROE
5.93%
Weak
P/E
42.16x
Expensive
Debt / Equity
0.00
Low
Industry
Healthcare
Hospital
Overall View
Mixed
Price performance
Day₹83.10
₹86.95
52W₹50.05
₹156.35
DocStoX take
Supported by growth (7.5) and risk (7.5), but held back by valuation (0.4). Growth looks strong at 7.5, but that is offset by valuation at 0.4 and momentum at 2.7. We are calling it Mixed rather than resolving the conflict for you.
DocStoX score
Low confidence4.3
/10
Weak
Quality
Modest
ROE 5.9%
Valuation
Expensive
P/E 42.2×
Growth
Strong
Revenue +117.6% 5Y CAGR
Risk
Low risk
D/E 0.00
Momentum
Weak
34% of 52-week range
At a glance
Market Cap
₹142 Cr
52W High / Low
₹156 / ₹50
Dividend Yield
—
Promoter Holding
61.71%
EPS (TTM)
₹2.04
Book Value
₹34.49
Key highlights
- Revenue compounding 118% a year
- Profit compounding 106% a year
- Low leverage — D/E 0.00
- Valuation is weak (0.4/10)
- Small ₹142 cr company — thinner liquidity
3 Positives2 Watchouts
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Healthcare stocks · Hospital
Explore Nephro Care India Limited’s valuation
Free deep-dive tools · no sign-up
Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.
Nephro Care India Limited peers in Healthcare
Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.
Sun Pharmaceutical Industries LimitedDivi's Laboratories LimitedTorrent Pharmaceuticals LimitedApollo Hospitals Enterprise LimitedZydus Lifesciences LimitedLaurus Labs LimitedCipla LimitedDr. Reddy's Laboratories LimitedAurobindo Pharma LimitedMankind Pharma LimitedLupin LimitedManipal Health Enterprises Limited
Compare Nephro Care India Limited with peers
Nephro Care India Limited vs Sun Pharmaceutical Industries LimitedNephro Care India Limited vs Divi's Laboratories LimitedNephro Care India Limited vs Torrent Pharmaceuticals LimitedNephro Care India Limited vs Apollo Hospitals Enterprise LimitedNephro Care India Limited vs Zydus Lifesciences LimitedNephro Care India Limited vs Laurus Labs Limited
Related tools & concepts
Value Nephro Care India Limited with the ratios and calculators DocStoX uses in its analysis.
P/E RatioPrice to earningsReturn on Equity (ROE)ProfitabilityROCECapital efficiencyDebt to EquityLeverageP/B RatioPrice to bookNet Profit MarginBottom-line efficiencyDCF / Intrinsic ValueEstimate fair valueCAGR CalculatorAnnualised returnDividend YieldIncome on pricePosition SizeRisk-based sizingBrokerage CalculatorCharges on a tradeSIP CalculatorSystematic investing